論文

基本情報

氏名 井上 貴史
氏名(カナ) イノウエ タカシ
氏名(英語) Inoue Takashi
所属 獣医学部 獣医学科
職名 教授
researchmap研究者コード B000003480
researchmap機関 岡山理科大学

題名

Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets

単著・共著の別

 

著者

Shotaro Uehara
Mirai Kawano
Norie Murayama
Yasuhiro Uno
Masahiro Utoh
Takashi Inoue
Erika Sasaki
Hiroshi Yamazaki

概要

Racemic omeprazole has been used for clinically treating gastric acid-related diseases and also as a typical human cytochrome P450 (P450) 2C19 probe substrate in preclinical studies. S-Omeprazole has been developed as a single enantiomer medicine, which has been reported not to be associated with polymorphic human P450 2019 phenotypes. In this study, 5-hydroxylation and sulfoxidation activities, with respect to stereoselective R- and S-omeprazole oxidations by liver microsomes from experimental animals including non-human primates and humans, were investigated in vitro. Liver microsomes from humans, cynomolgus monkeys, and mice preferentially mediated R-omeprazole 5-hydroxylations, however those from marmosets, minipigs, dogs, and rats preferentially mediated S-omeprazole 5-hydroxylations. High catalytic activities were observed for recombinant human P450 2019 in Romeprazole 5-hydroxlations, cynomolgus monkey P450 2C19 in both R- and S-omeprazole 5-hydroxlations, and marmoset P450 2019 in S-omeprazole 5-hydroxlations. On the other hand, human, cynomolgus monkey, and marmoset P450 3A enzymes preferentially mediated S-omeprazole sulfoxidations. Correlation and kinetic analyses revealed a high affinity of polymorphic cynomolgus monkey and marmoset liver microsomal P450 2019 enzymes with respect to R- and S-omeprazole 5-hydroxylations, respectively, and a high capacity of cynomolgus monkey and marmoset liver microsomal P450 3A4 for omeprazole 5-hydroxylations and sulfoxidations. R- and S-omeprazole 5-hydroxylation activities in cynomolgus monkey and marmoset liver microsomes were significantly different among wild-type, heterozygous, and homozygous animals genotyped for cynomolgus monkey P450 2C19 p.[(Phe100Asn; Ala103Va1; Ile1 12Leu)] and for marmoset P450 2C19 p.[(Phe7Leu; Ser254Leu; Ile469Thr)1, respectively. The results of this study demonstrate polymorphic cynomolgus monkey and marmoset P450 2C19 dependent omeprazole oxidation activities with individual variations similar to humans. (C) 2016 Elsevier Inc. All rights reserved.

発表雑誌等の名称

BIOCHEMICAL PHARMACOLOGY

出版者

PERGAMON-ELSEVIER SCIENCE LTD

120

 

開始ページ

56

終了ページ

62

発行又は発表の年月

2016-11

査読の有無

有り

招待の有無

無し

記述言語

英語

掲載種別

研究論文(学術雑誌)

ISSN

 

ID:DOI

10.1016/j.bcp.2016.09.010

ID:NAID(CiNiiのID)

 

ID:PMID

 

JGlobalID

 

arXiv ID

 

ORCIDのPut Code

 

DBLP ID